Gravistat

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-1992
01219761992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Serum concentration profiles and pharmacokinetic parameters (cmax, tmax, AUC24, AUC0-00, MRT) of ethinylestradiol (EE2) and… (More)
Is this relevant?
1991
1991
Pharmacokinetic investigations (c0h, c2h, c6h, c24h, AUC24) were carried out both in the first and last four days of a treatment… (More)
Is this relevant?
1991
1991
In 8 female sports students (runners) aged 20 and 21 years and 10 women between 20 and 40 years of age, who regularly underwent… (More)
Is this relevant?
1990
1990
A radioimmunoassay for ethinylestradiol (EE2) which was developed in the pharmacological department of VEB Jenapharm has been… (More)
Is this relevant?
1987
1987
The effect of the estrogen-progesteron-combinations Gravistat (0.05 mg ethynylestradiol and 0.125 mg levonorgestrel) on glucose… (More)
Is this relevant?
1986
1986
The author observed 120 women using the contraceptive preparation Gravistat over a 2-year period. The aim of this research was to… (More)
Is this relevant?
1981
1981
The present paper deals with the effects of the hormonal contraceptives Deposiston and Gravistat on the digestibility of dietary… (More)
Is this relevant?
1978
1978
In 200 women who on the average 5.6 years took ovosiston and/or non-ovlon, and in 40 women who during the last three months had… (More)
Is this relevant?
1977
1977
Total protein fractions in the serum were measured in 213 women who used various contraceptive preparations (53 used Gravistat… (More)
Is this relevant?
1977
1977
In order to check the long-term effects of oral contraceptives used in the GDR on certain serum-lipid-fractions, triglycerides… (More)
Is this relevant?